While IGFBP-3 can suppress BC cell growth and promote apoptosis in vitro, Mendelian randomization analyses indicate no significant link between genetically predicted IGFBP-3 levels and BC risk [61]. The gene discussed is IGFBP3; the disease is breast cancer.